Follow

Cytovac AB

Nasdaq First North GM (Sweden)

Cytovac is a growing Danish biotech company, which has chosen to focus on development of a cancer treatment that uses the body’s own immune system.

Sector:
HEALTH CARE
Current instruments
News
No available news yet for Cytovac AB
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North GM
Sweden (SE)
Details of share in Cytovac AB with ticker
Status
Active
Amount of instruments
Currency
SEK
Type
Price
Pre-money
Time
Files
Listing
2021
Direct listing of Cytovac AB on Nasdaq First North GM
People
Lone Dahl Andersen
CEO
Jan Kuhlmann Andersen
Chairman of the board
Peter Bonne Eriksen
Board member
Per Falholt
Board member
Fredrik Buch
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Venlighedsvej 6
Zip code
2970
City/district
Hørsholm
Country
Denmark (DK)
Registration number
559162-3318
LEI code
254900ZMD4W3LK9YET12
First trade date
Registration date
14 Jun 2018
Short name
Cytovac

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More